Access cutting-edge alzheimer's disease treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access alzheimer's disease specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alzheimer's disease treatment provided free
The purpose is to evaluate the biomarker effect, safety, and tolerability of investigational study drugs in participants who are known to have an Alzheimer's disease (AD)-causing mutation. Stage 1 will determine if treatment with the study drug prevents or slows the rate of amyloid beta (Aβ) pathological disease accumulation demonstrated by Aβ positron emission tomography (PET) imaging. Stage 2 will evaluate the effect of early Aβ plaque reduction/prevention on disease progression by assessing d
Sponsor: Washington University School of Medicine
Check if you qualify for this alzheimer's disease clinical trial in St Louis, MO
If you're searching for alzheimer's disease treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.